Zydus and Synthon ink licensing and supply agreement for Ozanimod Capsules for US market
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
These medicines are essential in preventing RhD immunisation during pregnancy
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
The company expects meaningful revenue contribution from this long-term agreement
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
The supply of these goods is set to commence within the first quarter of FY26
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
Subscribe To Our Newsletter & Stay Updated